Access practical guides, ROI calculators, and success stories designed to help you benchmark and improve your revenue cycle.
HealthCell bills for bone marrow biopsies, transfusion services, hematologic malignancy management, coagulation disorder treatment, and infusion therapy including iron infusions and clotting factor administration. Our billers are trained on the complex coding requirements of hematology. We also manage billing for genomic and molecular testing increasingly used in hematologic malignancy diagnosis and treatment planning.
Infusion billing in hematology requires precise sequencing of drug administration codes, correct hydration coding, and HCPCS J-codes for drugs. HealthCell ensures each infusion session is billed accurately—capturing all administration levels and drug costs—to avoid revenue leakage. Our billers are also trained on infusion suite billing to ensure nursing time, supplies, and facility costs are captured where reimbursable.
Yes. We manage prior authorizations for specialty infusions, gene therapies, and high-cost hematology drugs. Our team tracks authorization windows and re-authorization timelines to prevent lapses that could result in unexpected denials. We also manage appeals when payers deny authorizations for medically necessary treatments, supporting your clinical team with documentation and clinical criteria review.
We stay current with CMS and payer policies for hematology-oncology overlap services, 340B drug pricing rules, and infusion center compliance. Regular audits help your practice stay ahead of evolving reimbursement requirements. Our compliance team also monitors OIG work plan items and RAC audit trends relevant to hematology to keep your practice prepared for external review.
Hematology billing involves high-cost drug administration, complex infusion coding, oncology overlap, and frequent payer scrutiny. HealthCell’s specialized team navigates these challenges with precision—protecting your revenue and ensuring compliant billing for every patient encounter. We also help hematology practices track drug cost versus reimbursement to identify financial risks before they affect the practice bottom line.
The trusted financial backbone for independent practices—stable collections, fewer denials, and freedom to focus on care.
